Short Stature Diagnosis and Referral

Mohamad Maghnie, José I Labarta, Ekaterina Koledova, Tilman R Rohrer, Mohamad Maghnie, José I Labarta, Ekaterina Koledova, Tilman R Rohrer

Abstract

The "360° GH in Europe" meeting, which examined various aspects of GH diseases, was held in Lisbon, Portugal, in June 2016. The Merck KGaA (Germany) funded meeting comprised three sessions entitled "Short Stature Diagnosis and Referral," "Optimizing Patient Management," and "Managing Transition." Each session had three speaker presentations, followed by a discussion period, and is reported as a manuscript, authored by the speakers. The first session examined current processes of diagnosis and referral by endocrine specialists for pediatric patients with short stature. Requirements for referral vary widely, by country and by patient characteristics such as age. A balance must be made to ensure eligible patients get referred while healthcare systems are not over-burdened by excessive referrals. Late referral and diagnosis of non-GH deficiency conditions can result in increased morbidity and mortality. The consequent delays in making a diagnosis may compromise the effectiveness of GH treatment. Algorithms for growth monitoring and evaluation of skeletal disproportions can improve identification of non-GH deficiency conditions. Performance and validation of guidelines for diagnosis of GH deficiency have not been sufficiently tested. Provocative tests for investigation of GH deficiency remain equivocal, with insufficient information on variations due to patient characteristics, and cutoff values for definition differ not only by country but also by the assay used. When referring and diagnosing causes of short stature in pediatric patients, clinicians need to rely on many factors, but the most essential is clinical experience.

Keywords: diagnosis; growth hormone; patient management; referral; short stature.

References

    1. Ranke MB, Lindberg A, KIGS International Board . Early-onset idiopathic growth hormone deficiency within KIGS. Horm Res (2003) 60(Suppl 1):18–21.10.1159/000071221
    1. Bidlingmaier M, Freda PU. Measurement of human growth hormone by immunoassays: current status, unsolved problems and clinical consequences. Growth Horm IGF Res (2010) 20:19–25.10.1016/j.ghir.2009.09.005
    1. Wagner IV, Paetzold C, Gausche R, Vogel M, Koerner A, Thiery J, et al. Clinical evidence-based cutoff limits for GH stimulation tests in children with a backup of results with reference to mass spectrometry. Eur J Endocrinol (2014) 171:389–97.10.1530/EJE-14-0165
    1. Eskes SA, Tomasoa NB, Endert E, Geskus RB, Fliers E, Wiersinga WM. Establishment of reference values for endocrine tests. Part VII: growth hormone deficiency. Neth J Med (2009) 67:127–33.
    1. Stanley TL, Levitsky LL, Grinspoon SK, Misra M. Effect of body mass index on peak growth hormone response to provocative testing in children with short stature. J Clin Endocrinol Metab (2009) 94:4875–81.10.1210/jc.2009-1369
    1. Richmond E, Rogol AD. Current indications for growth hormone therapy for children and adolescents. Endocr Dev (2010) 18:92–108.10.1159/000316130
    1. Navarro R, Dunn JD, Lee PA, Owens GM, Rapaport R. Translating clinical guidelines into practice: the effective and appropriate use of growth hormone. Am J Manag Care (2013) 19(15 Suppl):s281–9.
    1. Acerini C, Wac K, Bang P, Lehwalder D. Optimizing patient management and adherence for children receiving growth hormone. Front Endocrinol (2017) 8:313.10.3389/fendo.2017.00313
    1. Hauffa BP, Touraine P, Urquhart T, Koledova E. Managing transition in patients treated with growth hormone. Front Endocrinol (2017) 8:346.10.3389/fendo.2017.00346
    1. Oostdijk W, Grote FK, de Muinck Keizer-Schrama SM, Wit JM. Diagnostic approach in children with short stature. Horm Res (2009) 72:206–17.10.1159/000236082
    1. Savage MO, Backeljauw PF, Calzada R, Cianfarani S, Dunkel L, Koledova E, et al. Early detection, referral, investigation, and diagnosis of children with growth disorders. Horm Res Paediatr (2016) 85:325–32.10.1159/000444525
    1. Grote FK, Oostdijk W, de Muinck Keizer-Schrama SM, Dekker FW, Verkerk PH, Wit JM. Growth monitoring and diagnostic work-up of short stature: an international inventorization. J Pediatr Endocrinol Metab (2005) 18:1031–8.10.1515/JPEM.2005.18.11.1031
    1. van Buuren S, Bonnemaijer-Kerckhoffs DJ, Grote FK, Wit JM, Verkerk PH. Many referrals under Dutch short stature guidelines. Arch Dis Child (2004) 89(4):351–2.10.1136/adc.2003.038208
    1. Stalman SE, Hellinga I, van Dommelen P, Hennekam RC, Saari A, Sankilampi U, et al. Application of the Dutch, Finnish and British screening guidelines in a cohort of children with growth failure. Horm Res Paediatr (2015) 84:376–82.10.1159/000440652
    1. Grimberg A, Huerta-Saenz L, Grundmeier R, Ramos MJ, Pati S, Cucchiara AJ, et al. Gender bias in U.S. pediatric growth hormone treatment. Sci Rep (2015) 5:11099.10.1038/srep11099
    1. Yardeni D, Loewenthal N, Limony Y, Hershkovitz E. Ethnic and gender inequalities in the evaluation of referred short children. Horm Res Paediatr (2011) 76:50–5.10.1159/000325705
    1. Saari A, Sankilampi U, Dunkel L. Multiethnic WHO growth charts may not be optimal in the screening of disorders affecting height: turner syndrome as a model. JAMA Pediatr (2013) 167:194–5.10.1001/jamapediatrics.2013.436
    1. Machogu E, Cao Y, Miller T, Simpson P, Levy H, Quintero D, et al. Comparison of WHO and CDC growth charts in predicting pulmonary outcomes in cystic fibrosis. J Pediatr Gastroenterol Nutr (2015) 60:378–83.10.1097/MPG.0000000000000610
    1. Scherdel P, Dunkel L, van Dommelen P, Goulet O, Salaün JF, Brauner R, et al. Growth monitoring as an early detection tool: a systematic review. Lancet Diabetes Endocrinol (2016) 4(5):447–56.10.1016/S2213-8587(15)00392-7
    1. Grote FK, van Dommelen P, Oostdijk W, de Muinck Keizer-Schrama SM, Verkerk PH, Wit JM, et al. Developing evidence-based guidelines for referral for short stature. Arch Dis Child (2008) 93:212–7.10.1136/adc.2007.120188
    1. Gascoin-Lachambre G, Brauner R, Duche L, Chalumeau M. Pituitary stalk interruption syndrome: diagnostic delay and sensitivity of the auxological criteria of the growth hormone research society. PLoS One (2011) 6(1):e16367.10.1371/journal.pone.0016367
    1. Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. J Clin Endocrinol Metab (2000) 85:3990–3.10.1210/jc.85.11.3990
    1. Saari A, Harju S, Mäkitie O, Saha MT, Dunkel L, Sankilampi U. Systematic growth monitoring for the early detection of celiac disease in children. JAMA Pediatr (2015) 169:e1525.10.1001/jamapediatrics.2015.25
    1. Stochholm K, Juul S, Juel K, Naeraa RW, Gravholt CH. Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab (2006) 91:3897–902.10.1210/jc.2006-0558
    1. Saari A, Sankilampi U, Hannila ML, Saha MT, Mäkitie O, Dunkel L. Screening of turner syndrome with novel auxological criteria facilitates early diagnosis. J Clin Endocrinol Metab (2012) 97:E2125–32.10.1210/jc.2012-1739
    1. Sisley S, Trujillo MV, Khoury J, Backeljauw P. Low incidence of pathology detection and high cost of screening in the evaluation of asymptomatic short children. J Pediatr (2013) 163:1045–51.10.1016/j.jpeds.2013.04.002
    1. Cohen P, Rogol AD, Deal CL, Saenger P, Reiter EO, Ross JL, et al. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab (2008) 93:4210–7.10.1210/jc.2008-0509
    1. Duché L, Trivin C, Chemaitilly W, Souberbielle JC, Bréart G, Brauner R, et al. Selecting short-statured children needing growth hormone testing: derivation and validation of a clinical decision rule. BMC Pediatr (2008) 8:29.10.1186/1471-2431-8-29
    1. Wit JM, Kiess W, Mullis P. Genetic evaluation of short stature. Best Pract Res Clin Endocrinol Metab (2011) 25:1–17.10.1016/j.beem.2010.06.007
    1. Binder G. Short stature due to SHOX deficiency: genotype, phenotype, and therapy. Horm Res Paediatr (2011) 75:81–9.10.1159/000324105
    1. Donaldson MD, Gault EJ, Tan KW, Dunger DB. Optimising management in Turner syndrome: from infancy to adult transfer. Arch Dis Child (2006) 91:513–20.10.1136/adc.2003.035907
    1. Hong YH, Shin YL. Turner syndrome masquerading as normal early puberty. Ann Pediatr Endocrinol Metab (2014) 19:225–8.10.6065/apem.2014.19.4.225
    1. van der Burgt I. Noonan syndrome. Orphanet J Rare Dis (2007) 2:4.10.1186/1750-1172-2-4
    1. Saari A, Sankilampl U, Hannila ML, Kiviniemi V, Kesseli K, Dunkel L. New Finnish growth references for children and adolescents aged 0 to 20 years: length/height-for-age, weight-for-length/height, and body mass index-for-age. Ann Med (2011) 43:235–48.10.3109/07853890.2010.515603
    1. Sankilampi U, Saari A, Laine T, Miettinen PJ, Dunkel L. Use of electronic health records for automated screening of growth disorders in primary care. JAMA (2013) 310:1071–2.10.1001/jama.2013.218793
    1. Hoepffner W, Pfäffle R, Gausche R, Meigen C, Keller E. Early detection of growth disorders with the CrescNet system at the Leipzig treatment center. Dtsch Arztebl Int (2011) 108:123–8.10.3238/arztebl.2011.0123
    1. Voigt M, Fusch C, Olbertz D, Hartmann K, Rochow N, Renken C, et al. Analysis of the neonatal collective in the Federal Republic of Germany 12th report. Presentation of detailed percentiles for the body measurement of newborns (in German). Geburtshilfe Frauenheilkd (2006) 66:956–70.10.1055/s-2006-924458
    1. Hoffmann PF, Jung AM, Stierkorb E, Monz D, Gortner L, Rohrer TR. Down syndrome: gestational age-related neonatal anthropometrics for Germany. Neonatology (2016) 109:195–202.10.1159/000442812
    1. Ranke MB, Lindberg A, Tanaka T, Camacho-Hübner C, Dunger DB, Geffner ME. Baseline characteristics and gender differences in prepubertal children treated with growth hormone in Europe, UAS, and Japan: 25 years’ KIGS experience (1987–2012) and review. Horm Res Paediatr (2017) 87:30–41.10.1159/000452887
    1. Grimberg A, DiVall SA, Polychronakos C, Allen DB, Cohen LE, Quintos JB, et al. Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency. Horm Res Paediatr (2016) 86:361–97.10.1159/000452150
    1. Maghnie M, Valtorta A, Moretta A, Larizza D, Preti P, Palladini G, et al. Diagnosing growth hormone deficiency: the value of short-term hypocaloric diet. J Clin Endocrinol Metab (1993) 77:1372–8.10.1210/jcem.77.5.8077335
    1. Maghnie M, Salati B, Bianchi S, Rallo M, Tinelli C, Autelli M, et al. Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone plus arginine in children and adults with congenital hypopituitarism. J Clin Endocrinol Metab (2001) 86:1575–9.10.1210/jc.86.4.1574
    1. Husbands S, Ong KK, Gilbert J, Wass JA, Dunger DB. Increased insulin sensitivity in young, growth hormone deficient children. Clin Endocrinol (Oxf) (2001) 55:87–92.10.1046/j.1365-2265.2001.01298.x
    1. Secco A, di Iorgi N, Napoli F, Calandra E, Ghezzi M, Frassinetti C, et al. The glucagon test in the diagnosis of growth hormone deficiency in children with short stature younger than 6 years. J Clin Endocrinol Metab (2009) 94:4251–7.10.1210/jc.2009-0779
    1. Guzzetti C, Ibba A, Pilia S, Beltrami N, Di Iorgi N, Rollo A, et al. Cut-off limits of the peak GH response to stimulation tests for the diagnosis of GH deficiency in children and adolescents: study in patients with organic GHD. Eur J Endocrinol (2016) 175:41–7.10.1530/EJE-16-0105
    1. Hauffa BP, Lehmann N, Bettendorf M, Mehls O, Dörr HG, Partsch CJ, et al. Central reassessment of GH concentrations measured at local treatment centers in children with impaired growth: consequences for patient management. Eur J Endocrinol (2004) 150:291–7.10.1530/eje.0.1500291
    1. Juul A, Bernasconi S, Clayton PE, Kiess W, DeMuinck-Keizer Schrama S. Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology (ESPE). European audit of current practice in diagnosis and treatment of childhood growth hormone deficiency. Horm Res (2002) 58:233–41.10.1159/000066265
    1. Maghnie M, Lindberg A, Koltowska-Häggström M, Ranke MB. Magnetic resonance imaging of CNS in 15,043 children with GH deficiency in KIGS (Pfizer International Growth Database). Eur J Endocrinol (2013) 168:211–7.10.1530/EJE-12-0801
    1. Deal CL, Tony M, Höybye C, Allen DB, Tauber M, Christiansen JS, et al. Growth Hormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader–Willi syndrome. J Clin Endocrinol Metab (2013) 98:E1072–87.10.1210/jc.2012-3888
    1. Hughes IP, Choong C, Rath S, Atkinson H, Cotterill A, Cutfield W, et al. Early cessation and non-response are important and possibly related problems in growth hormone therapy: an OZGROW analysis. Growth Horm IGF Res (2016) 29:63–70.10.1016/j.ghir.2016.04.006
    1. Hughes I, Harris M, Cotterill A, Garnett S, Bannink E, Pennell C, et al. Comparison of Centers for Disease Control and Prevention and World Health Organization references/standards for height in contemporary Australian children: analyses of the Raine Study and Australian National Children’s Nutrition and Physical Activity cohorts. J Paediatr Child Health (2014) 50:895–901.10.1111/jpc.12672
    1. Binder G, Weidenkeller M, Blumenstock G, Langkamp M, Weber K, Franz AR. Rational approach to the diagnosis of severe growth hormone deficiency in the newborn. J Clin Endocrinol Metab (2010) 95:2219–26.10.1210/jc.2009-2692

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅